BRPI0922710A2 - método para a produção de plaquetas - Google Patents

método para a produção de plaquetas

Info

Publication number
BRPI0922710A2
BRPI0922710A2 BRPI0922710A BRPI0922710A BRPI0922710A2 BR PI0922710 A2 BRPI0922710 A2 BR PI0922710A2 BR PI0922710 A BRPI0922710 A BR PI0922710A BR PI0922710 A BRPI0922710 A BR PI0922710A BR PI0922710 A2 BRPI0922710 A2 BR PI0922710A2
Authority
BR
Brazil
Prior art keywords
platelets
production
Prior art date
Application number
BRPI0922710A
Other languages
English (en)
Inventor
Claire Dunois-Larde
Dominique Baruch
Elisabeth Cramer-Borde
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of BRPI0922710A2 publication Critical patent/BRPI0922710A2/pt
Publication of BRPI0922710A8 publication Critical patent/BRPI0922710A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
BRPI0922710A 2008-12-04 2009-12-04 método para a produção de plaquetas BRPI0922710A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08305881 2008-12-04
PCT/EP2009/066401 WO2010063823A1 (en) 2008-12-04 2009-12-04 Method for producing platelets

Publications (2)

Publication Number Publication Date
BRPI0922710A2 true BRPI0922710A2 (pt) 2016-01-05
BRPI0922710A8 BRPI0922710A8 (pt) 2018-06-26

Family

ID=40756593

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922710A BRPI0922710A8 (pt) 2008-12-04 2009-12-04 método para a produção de plaquetas

Country Status (16)

Country Link
US (1) US9012221B2 (pt)
EP (1) EP2352815B1 (pt)
JP (1) JP5863459B2 (pt)
CN (2) CN104087552A (pt)
AU (1) AU2009324042B2 (pt)
BR (1) BRPI0922710A8 (pt)
CA (1) CA2745268C (pt)
CY (1) CY1117452T1 (pt)
DK (1) DK2352815T3 (pt)
ES (1) ES2569610T3 (pt)
HR (1) HRP20160404T8 (pt)
HU (1) HUE027112T2 (pt)
PL (1) PL2352815T3 (pt)
SI (1) SI2352815T1 (pt)
SM (1) SMT201600131B (pt)
WO (1) WO2010063823A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686420B1 (en) * 2011-03-18 2017-03-01 New York Blood Center, Inc. Megakaryocyte and platelet production from stem cells
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
AU2013371589C1 (en) 2013-01-03 2020-09-24 Brigham And Women's Hospital, Inc. System and method for a biomimetic fluid processing
EP3071327B1 (en) 2013-11-19 2025-06-11 HemostOD SA Fluidic device for producing platelets
JP2015181406A (ja) * 2014-03-24 2015-10-22 東レエンジニアリング株式会社 血小板産生装置および血小板産生方法
AU2015241133B2 (en) * 2014-03-31 2019-11-28 Brigham And Women's Hospital, Inc. Systems and methods for biomimetic fluid processing
US10538738B2 (en) * 2014-05-19 2020-01-21 Eleftherios Papoutsakis Megakaryocytic particles and microparticles for cell therapy and fate modification of stem and progenitor cells
EP3294871B1 (en) * 2015-05-12 2026-04-29 HemostOD SA Combination of pharmacological and microfluidic features for improved platelets production
WO2016204256A1 (ja) * 2015-06-16 2016-12-22 国立大学法人京都大学 高機能性血小板の製造方法
AU2016321116B2 (en) * 2015-09-08 2023-05-18 Brigham And Women's Hospital, Inc. System and method for producing blood platelets
US10570372B2 (en) 2015-09-15 2020-02-25 Megakaryon Corporation Method for manufacturing platelets by rotary stirring culture method
RU2766177C2 (ru) * 2015-10-14 2022-02-08 Мегакарион Корпорейшн Способ получения очищенных тромбоцитов
ES2833357T3 (es) * 2015-11-02 2021-06-15 Megakaryon Corp Procedimiento de preparación de plaquetas con un dispositivo de agitación recíproca
WO2018237061A1 (en) * 2017-06-20 2018-12-27 Northwestern University Microfluidic platelet bioreactor device and systems
CA3087344A1 (en) 2018-01-05 2019-07-11 Platelet Biogenesis, Inc. Compositions and methods for producing megakaryocytes
JP2021529770A (ja) 2018-06-29 2021-11-04 プレートレット バイオジェネシス, インコーポレイテッド 薬物送達のための組成物およびその使用方法
BR112021000996A2 (pt) 2018-07-19 2021-04-20 Platelet Biogenesis, Inc. biorreator de recirculação empilhado
FR3101885B1 (fr) * 2019-10-11 2024-11-08 Francais Du Sang Ets Systeme pour la liberation de plaquettes et procede de liberation de plaquettes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344560A (en) * 1979-11-02 1982-08-17 Asahi Kasei Kogyo Kabushiki Kaisha Container, apparatus and method for separating platelets
DE19956156A1 (de) * 1999-11-23 2001-06-13 Univ Eberhard Karls Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
NZ554866A (en) * 2004-11-01 2010-12-24 Wisconsin Alumni Res Found Platelets from stem cells
SI1836500T1 (sl) * 2005-01-14 2010-11-30 Ablynx Nv Postopki in testi za razlikovanje med različnimioblikami bolezni in motenj ki so označene s trombocitopenijo in ali s spontano interakcijo med von Willebrandovim faktorjem vWF in krvnimi ploščicami
JP5419076B2 (ja) * 2008-05-15 2014-02-19 旭化成メディカル株式会社 血小板の誘導方法

Also Published As

Publication number Publication date
CY1117452T1 (el) 2017-04-26
EP2352815A1 (en) 2011-08-10
EP2352815B1 (en) 2016-02-10
HUE027112T2 (en) 2016-08-29
HRP20160404T1 (hr) 2016-06-17
BRPI0922710A8 (pt) 2018-06-26
CA2745268A1 (en) 2010-06-10
AU2009324042B2 (en) 2014-12-04
JP2012510804A (ja) 2012-05-17
HK1165491A1 (en) 2012-10-05
ES2569610T3 (es) 2016-05-11
SI2352815T1 (sl) 2016-10-28
CN102300984A (zh) 2011-12-28
US20120014933A1 (en) 2012-01-19
WO2010063823A1 (en) 2010-06-10
CN104087552A (zh) 2014-10-08
HRP20160404T8 (hr) 2016-07-01
US9012221B2 (en) 2015-04-21
DK2352815T3 (en) 2016-05-17
CN102300984B (zh) 2014-06-04
CA2745268C (en) 2018-11-13
PL2352815T3 (pl) 2016-07-29
SMT201600131B (it) 2016-07-01
JP5863459B2 (ja) 2016-02-16
AU2009324042A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
BRPI0922710A8 (pt) método para a produção de plaquetas
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
PT2639223T (pt) Processos para produção de ácidos cicloalquilcarboxamido-piridinabenzoicos
BRPI1012370A2 (pt) processo para a produção de olefinas
FI20075434L (fi) Prosessi haaroittuneiden hiilivetyjen valmistamiseksi
BR112012003615A2 (pt) processo para a produção de butadieno
BRPI0810238A2 (pt) Processo para produção de pcc
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0819238A2 (pt) Métodos para a produção de caseína
BRPI1014812A2 (pt) Processo para a produção de alacoóis
FI20075433L (fi) Prosessi haaroittuneiden hiilivetyjen valmistamiseksi
PL2160432T3 (pl) Sposób wytwarzania poliamidów
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BR112012001078A2 (pt) Método para a produção de derivados de sulfóxido de 3-triazolila quirais
BRPI0923299A8 (pt) método para a produção de minérios sinterizado
BRPI1012237A2 (pt) método para produção de hidrocarbonetos aromáticos
BR112012005418A2 (pt) processo para a produção de grânulos
BRPI0813921A2 (pt) Método para a produção de óxido de propileno
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BRPI0908900A2 (pt) processo para a produção de polióis
BRPI0919835A2 (pt) método para a produção de polímeros
BRPI0915080A2 (pt) dispositivos, processos e métodos para a produção de ésteres de alquílicos inferiores
BRPI1008117A2 (pt) Processo para a sintese de cleistantina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements